Investigating the Effect of Caffeine Consumption on Speech Understanding in Noise in Young Adults
2 other identifiers
interventional
60
1 country
1
Brief Summary
Caffeine is a widely consumed substance worldwide and is often used to increase alertness and improve cognitive functions. Caffeine stimulates brain activity by binding to adenosine receptors, which increases alertness instead of sleepiness. Studies on the effects of caffeine on cognitive functions have shown that it improves basic cognitive functions such as attention, reaction time, and alertness, while a less pronounced effect is seen on sensory functions such as vision and hearing. However, no study has been found investigating the effect of caffeine consumption on understanding speech in noise. Understanding speech in noise is a skill that includes not only auditory functions but also cognitive functions. This skill is affected by cognitive elements such as selective attention and executive functions. In this context, it is thought that this study, which aims to examine the relationship between caffeine and understanding speech in noise, will contribute to the literature. 60 participants between the ages of 18-30 will be included in this study. Participants will consist of individuals without hearing loss (SSO\<25 dB nHL), no history of neurological or psychological disorders, non-smokers, and those who do not use ototoxic drugs. Participants will be randomly divided into a placebo group that consumes decaffeinated coffee and a study group that consumes coffee containing 300 mg caffeine. The Turkish Matrix Test will be administered 30 minutes after coffee consumption. In addition, participants will be asked to keep a caffeine diary for one week to determine their daily caffeine consumption and will be asked to fill out the Caffeine Use Disorder Scale. Thus, they will be divided into low and high caffeine consumption groups and their speech understanding skills in noise will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2025
CompletedFirst Submitted
Initial submission to the registry
April 14, 2025
CompletedFirst Posted
Study publicly available on registry
April 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2026
CompletedApril 24, 2025
April 1, 2025
5 months
April 14, 2025
April 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Turkish Matrix Test
The test will be administered using the Oldenburg Measurement Application (OMA) software. Using the adaptive procedure, the signal-to-noise ratio (SNR-50) at which the individual repeats the words correctly at 50% will be found. Accordingly, the noise will be given continuously, kept constant at 65 dB SPL throughout the test. The test will start at 0 dB signal-to-noise ratio (SNR). There are sentences consisting of 5 words in the test. If the participant repeats at least three of the five words presented to him/her correctly, the SNR will decrease and if he/she does not repeat at least three words correctly, the SNR will increase. A total of 20 sentences will be presented to the participants.
Before and 30 minutes after drinking coffee
Secondary Outcomes (1)
Caffeine Use Disorder Scale
Before consuming caffeine.
Study Arms (2)
Experimental
EXPERIMENTALApproximately 280 grams of caffeine containing coffee is given.
Placebo
PLACEBO COMPARATORDecaffeinated coffee will be provided.
Interventions
Eligibility Criteria
You may qualify if:
- For both groups, it was planned to include individuals who had no hearing loss (SSO\<25 dB nHL), no history of neurological or psychological disorders, were non-smokers, and did not use ototoxic drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İstanbul Aydin University
Istanbul, Istanbul, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
April 14, 2025
First Posted
April 24, 2025
Study Start
April 12, 2025
Primary Completion
September 13, 2025
Study Completion
April 13, 2026
Last Updated
April 24, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share